Fecal Calprotectin Is Highly Effective to Detect Endoscopic Ulcerations in Crohn's Disease Regardless of Disease Location. Issue 7 (27th October 2020)
- Record Type:
- Journal Article
- Title:
- Fecal Calprotectin Is Highly Effective to Detect Endoscopic Ulcerations in Crohn's Disease Regardless of Disease Location. Issue 7 (27th October 2020)
- Main Title:
- Fecal Calprotectin Is Highly Effective to Detect Endoscopic Ulcerations in Crohn's Disease Regardless of Disease Location
- Authors:
- Buisson, Anthony
Mak, Wing Yan
Andersen, Michael J
Lei, Donald
Pekow, Joel
Cohen, Russell D
Kahn, Stacy A
Pereira, Bruno
Rubin, David T - Abstract:
- Abstract: Background: As the reliability of fecal calprotectin (Fcal) remains debatable to detect endoscopic ulcerations in patients with pure ileal Crohn's disease (CD), we aimed to compare its performances with those observed in patients with colonic or ileocolonic location. Methods: Using a prospectively maintained database, we analyzed 123 CD patients with Fcal measurement and ileocolonoscopy performed within 1 month with no therapeutic intervention during this interval. Receiver operating characterstic curves (ROC) were used to determine the best Fcal threshold to detect endoscopic ulcerations, taking into account the clinical relevance and usual recommended indices. Sensitivity, specificity, and positive (PPV) and negative predictive values (NPV) were presented with 95% confidence intervals. Results: The mean Fcal level was significantly higher in patients with endoscopic ulcerations in the L1 group ( P = 0.025) and the L2-L3 group ( P < 0.001). Using ROC curves, Fcal >200 µg/g and Fcal >250 µg/g were the best thresholds to detect endoscopic ulcerations in the L1 group (sensitivity = 75.0, 95% CI, 47.6–92.7; specificity = 87.5, 95% CI, 67.6–97.3; PPV = 80.0, 95% CI, 51.9–95.7; and NPV = 84.0; 95% CI, 63.9–95.5) and in the L2-L3 group (sensitivity = 84.1 95% CI, 69.9–93.4; specificity = 74.4, 95% CI, 57.9–87.0; PPV = 78.7, 95% CI, 64.3–89.3, and NPV = 80.6, 95% CI, 64.0–91.8), respectively. We compared the AUC between L1 and L2-L3 groups, and no difference was shownAbstract: Background: As the reliability of fecal calprotectin (Fcal) remains debatable to detect endoscopic ulcerations in patients with pure ileal Crohn's disease (CD), we aimed to compare its performances with those observed in patients with colonic or ileocolonic location. Methods: Using a prospectively maintained database, we analyzed 123 CD patients with Fcal measurement and ileocolonoscopy performed within 1 month with no therapeutic intervention during this interval. Receiver operating characterstic curves (ROC) were used to determine the best Fcal threshold to detect endoscopic ulcerations, taking into account the clinical relevance and usual recommended indices. Sensitivity, specificity, and positive (PPV) and negative predictive values (NPV) were presented with 95% confidence intervals. Results: The mean Fcal level was significantly higher in patients with endoscopic ulcerations in the L1 group ( P = 0.025) and the L2-L3 group ( P < 0.001). Using ROC curves, Fcal >200 µg/g and Fcal >250 µg/g were the best thresholds to detect endoscopic ulcerations in the L1 group (sensitivity = 75.0, 95% CI, 47.6–92.7; specificity = 87.5, 95% CI, 67.6–97.3; PPV = 80.0, 95% CI, 51.9–95.7; and NPV = 84.0; 95% CI, 63.9–95.5) and in the L2-L3 group (sensitivity = 84.1 95% CI, 69.9–93.4; specificity = 74.4, 95% CI, 57.9–87.0; PPV = 78.7, 95% CI, 64.3–89.3, and NPV = 80.6, 95% CI, 64.0–91.8), respectively. We compared the AUC between L1 and L2-L3 groups, and no difference was shown (0.89 vs 0.84, respectively, P = 0.46). We also compared 2-by-2 sensitivity, specificity, PPV, NPV, and accuracy and we did not observe any significant difference. Conclusion: Fecal calprotectin is highly effective to detect endoscopic ulcerations regardless of CD location but requires a lower cutoff value in patients with pure ileal involvement. … (more)
- Is Part Of:
- Inflammatory bowel diseases. Volume 27:Issue 7(2021)
- Journal:
- Inflammatory bowel diseases
- Issue:
- Volume 27:Issue 7(2021)
- Issue Display:
- Volume 27, Issue 7 (2021)
- Year:
- 2021
- Volume:
- 27
- Issue:
- 7
- Issue Sort Value:
- 2021-0027-0007-0000
- Page Start:
- 1008
- Page End:
- 1016
- Publication Date:
- 2020-10-27
- Subjects:
- Crohn's disease -- fecal calprotectin -- mucosal healing -- biomarker
Inflammatory bowel diseases -- Periodicals
Colitis, Ulcerative -- Periodicals
Crohn Disease -- Periodicals
Inflammatory Bowel Diseases -- Periodicals
616.344 - Journal URLs:
- http://journals.lww.com/ibdjournal/pages/default.aspx ↗
http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1536-4844/ ↗
http://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=toc&D=ovft&AN=00054725-000000000-00000 ↗
https://academic.oup.com/ibdjournal ↗
http://journals.lww.com ↗ - DOI:
- 10.1093/ibd/izaa269 ↗
- Languages:
- English
- ISSNs:
- 1078-0998
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4478.845400
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 24948.xml